发明名称 |
Therapeutische Verwendung von chimerischen und markierten Antikörpern, die gegen ein Differenzierung-Antigen gerichtet sind, dessen Expression auf menschliche B Lymphozyt beschränkt ist, für die Behandlung von B-Zell-Lymphoma |
摘要 |
Disclosed herein are therapeutic treatment protocols designed for the treatment of B cell lymphoma. These protocols are based upon therapeutic strategies which include the use of administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies, and cooperative strategies comprising the use of chimeric anti-CD20 antibodies and radiolabeled anti-CD20 antibodies. |
申请公布号 |
DE69329503(T2) |
申请公布日期 |
2001.05.03 |
申请号 |
DE1993629503T |
申请日期 |
1993.11.12 |
申请人 |
IDEC PHARMACEUTICALS CORP., SAN DIEGO |
发明人 |
ANDERSON, DARRELL R.;HANNA, NABIL;LEONARD, JOHN E.;NEWMAN, ROLAND A.;REFF, MITCHELL E.;RASTETTER, WILLIAM H. |
分类号 |
C12N15/02;A61K31/375;A61K31/573;A61K31/664;A61K31/704;A61K38/00;A61K39/395;A61K45/00;A61K47/48;A61K51/00;A61K51/08;A61K51/10;A61P35/00;C07K16/28;C07K16/46;C12N1/21;C12N5/02;C12N5/10;C12N15/09;C12P21/02;C12P21/08;C12R1/91;G01N33/53 |
主分类号 |
C12N15/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|